skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 36,846  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: resource type: Newsletter Articles remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
What is cardiomyopathy?
Material Type:
Newsletter Article
Add to My Research

What is cardiomyopathy?

Harvard Heart Letter, 2018

COPYRIGHT 2018 Harvard Health Publishing ;COPYRIGHT 2018 All Rights Reserved. ;Copyright © 2018 by Harvard University. All rights reserved. ;ISSN: 1051-5313 ;EISSN: 1943-510X

Full text available

2
‘Easygoing’ mother’s shock at stress-induced broken-heart syndrome diagnosis
Material Type:
Newsletter Article
Add to My Research

‘Easygoing’ mother’s shock at stress-induced broken-heart syndrome diagnosis

Press Association, 2024

Copyright Press Association Limited Jan 11, 2024

Digital Resources/Online E-Resources

3
4D Molecular Discloses Updated Data From Currently Paused Fabry Disease Cardiomyopathy Study
Material Type:
Newsletter Article
Add to My Research

4D Molecular Discloses Updated Data From Currently Paused Fabry Disease Cardiomyopathy Study

Benzinga Newswires, 2023

2020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.

Digital Resources/Online E-Resources

4
LianBio Touts Positive Data From Bristol Myers-Partnered Heart Drug In Chinese Patients
Material Type:
Newsletter Article
Add to My Research

LianBio Touts Positive Data From Bristol Myers-Partnered Heart Drug In Chinese Patients

Benzinga Newswires, 2023

2020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.

Digital Resources/Online E-Resources

5
Clinical Trial: Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy

US Fed News Service, Including US State News, 2024

Copyright HT Digital Streams Limited Apr 8, 2024

Digital Resources/Online E-Resources

6
Bristol Myers' Mavacamten Shows Sustained Improvements In Cardiovascular Outcomes In Cardiomyopathy Study
Material Type:
Newsletter Article
Add to My Research

Bristol Myers' Mavacamten Shows Sustained Improvements In Cardiovascular Outcomes In Cardiomyopathy Study

Benzinga Newswires, 2022

2020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.

Digital Resources/Online E-Resources

7
BridgeBio Pharma Highlights Mid-Stage Study Data Of Acoramidis In Cardiomyopathy Trial
Material Type:
Newsletter Article
Add to My Research

BridgeBio Pharma Highlights Mid-Stage Study Data Of Acoramidis In Cardiomyopathy Trial

Benzinga Newswires, 2022

2020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.

Digital Resources/Online E-Resources

8
Bristol Myers Squibb's Mavacamten Aces Late-Stage Trial In Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Bristol Myers Squibb's Mavacamten Aces Late-Stage Trial In Cardiomyopathy

Benzinga Newswires, 2022

2020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.

Digital Resources/Online E-Resources

9
Cardiomyopathy, one of the most common diseases in Spain: symptoms and how to prevent sudden death
Material Type:
Newsletter Article
Add to My Research

Cardiomyopathy, one of the most common diseases in Spain: symptoms and how to prevent sudden death

CE Noticias Financieras, 2024

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

10
Clinical Trial: Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling

US Fed News Service, Including US State News, 2024

Copyright HT Digital Streams Limited Apr 10, 2024

Digital Resources/Online E-Resources

11
Andrés Felipe Román doubts whether he will remain at Millonarios: the issue of his contract renewal is still in question
Material Type:
Newsletter Article
Add to My Research

Andrés Felipe Román doubts whether he will remain at Millonarios: the issue of his contract renewal is still in question

CE Noticias Financieras, 2022

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

12
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out? -- IBD
Material Type:
Newsletter Article
Add to My Research

BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out? -- IBD

Dow Jones Institutional News, 2024

Copyright Dow Jones & Company Inc. Mar 4, 2024

Digital Resources/Online E-Resources

13
Are you under 35 years old? This is the leading cause of sudden death
Material Type:
Newsletter Article
Add to My Research

Are you under 35 years old? This is the leading cause of sudden death

CE Noticias Financieras, 2024

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

14
Bristol Myers Squibb Announces Topline Results From Phase 3 VALOR-HCM Trial; Study Met Primary Endpoint At Week 16
Material Type:
Newsletter Article
Add to My Research

Bristol Myers Squibb Announces Topline Results From Phase 3 VALOR-HCM Trial; Study Met Primary Endpoint At Week 16

Benzinga Newswires, 2022

2020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.

Digital Resources/Online E-Resources

15
Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024
Material Type:
Newsletter Article
Add to My Research

Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024

News Bites - Healthcare & Equipment, 2024

Copyright News Bites Pty Ltd Jan 19, 2024

Digital Resources/Online E-Resources

16
BridgeBio Pharma Reports Positive Phase 3 Data for Cardiomyopathy Drug Trial
Material Type:
Newsletter Article
Add to My Research

BridgeBio Pharma Reports Positive Phase 3 Data for Cardiomyopathy Drug Trial

Dow Jones Institutional News, 2023

Copyright Dow Jones & Company Inc. Jul 17, 2023

Digital Resources/Online E-Resources

17
Cardiovascular Imaging Journal Issues Research Articles in Nov. 1, 2023 Edition
Material Type:
Newsletter Article
Add to My Research

Cardiovascular Imaging Journal Issues Research Articles in Nov. 1, 2023 Edition

Targeted News Service, 2023

Targeted News Service

Digital Resources/Online E-Resources

18
Millonarios president rules out lawsuit against Boca Juniors for Andrés Felipe Román
Material Type:
Newsletter Article
Add to My Research

Millonarios president rules out lawsuit against Boca Juniors for Andrés Felipe Román

CE Noticias Financieras, 2021

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

19
Clinical Trial: Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way

US Fed News Service, Including US State News, 2023

Copyright HT Digital Streams Limited May 10, 2023

Digital Resources/Online E-Resources

20
Andrés Felipe Román: step from being withdrawn by Boca's doctors to the call-up of the Colombian National Team
Material Type:
Newsletter Article
Add to My Research

Andrés Felipe Román: step from being withdrawn by Boca's doctors to the call-up of the Colombian National Team

CE Noticias Financieras, 2021

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

Results 1 - 20 of 36,846  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1997  (8)
  2. 1997 To 2002  (207)
  3. 2003 To 2008  (1,104)
  4. 2009 To 2015  (4,704)
  5. After 2015  (30,824)
  6. More options open sub menu

Subject 

  1. Cardiomyopathy  (8,816)
  2. Clinical Trials  (8,476)
  3. Stockholders  (6,668)
  4. Earnings Per Share  (5,963)
  5. Heart Failure  (4,968)
  6. Biotechnology Industry  (4,856)
  7. Patients  (4,538)
  8. Net Losses  (4,004)
  9. R&d  (3,860)
  10. Research & Development  (3,860)
  11. Investments  (3,532)
  12. Webcasting  (3,458)
  13. Cardiovascular Disease  (3,124)
  14. Corporate Profits  (3,099)
  15. Heart  (3,024)
  16. Stock Exchanges  (3,000)
  17. Disease  (2,941)
  18. Collaboration  (2,898)
  19. Fda Approval  (2,834)
  20. Pharmaceutical Industry  (2,681)
  21. More options open sub menu

Language 

  1. English  (36,816)
  2. Spanish  (15)
  3. German  (7)
  4. French  (5)
  5. Arabic  (3)
  6. Italian  (2)
  7. Hindi  (1)
  8. Urdu  (1)
  9. Portuguese  (1)
  10. More options open sub menu

Searching Remote Databases, Please Wait